神經外科市場規模、佔有率、成長分析、按產品、年齡層、適應症、分銷管道、最終用戶、地區 - 2025 年至 2032 年行業預測

2023 年全球神經外科市場規模價值 43 億美元，預計將從 2024 年的 45 億美元成長到 2032 年的 64.5 億美元，預測期間（2025-2032 年）的複合年成長率為 4.6%。

由於幾個關鍵因素，全球神經外科市場正在經歷顯著成長。神經外科手術的技術創新和設備的進步使得手術更加精確、微創，改善了患者的治療效果並縮短了恢復時間。人口老化日益加劇以及神經系統疾病發生率不斷上升，推動了神經外科介入的需求。此外，醫療保健組織和製藥公司之間的合作正在刺激治療方法創新。然而，該市場進入門檻很高，給新進入者帶來挑戰，包括需要專門的培訓和昂貴的設備。總體而言，隨著神經外科市場適應全球人口不斷變化的醫療保健需求，預計將繼續擴大。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和資料資料
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 案例研究分析

神經外科市場規模（按產品）

• 市場概況
• 神經介入設備
• 神經科學用內視鏡
• 神經外科手術演練
• 放射線手術系統
• 硬脊膜替代品
• 神經外科消融裝置
• 神經外科設備

神經外科市場規模（依年齡層分類）

• 市場概況
• 孩子們
• 成人
• 晚年

神經外科市場規模（依適應症分類）

• 市場概況
• 腦腫瘤
• 脊椎和顱底腫瘤
• 創傷性腦損傷
• 顱顏創傷
• 帕金森氏症
• 妥瑞症
• 其他

神經外科市場規模（按分銷管道）

• 市場概況
• 直接競標
• 第三方商家
• 其他

神經外科市場規模（按最終用戶分類）

• 市場概況
• 醫院和專科診所
• 門診手術中心
• 其他

神經外科市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分析市場佔有率
  • 收益與前一年同期比較（2022-2024 年）

主要企業簡介

• Elekta（Sweden）
• ALEVA NEUROTHERAPEUTICS（Switzerland）
• Machida Endoscope Co., Ltd.（Japan）
• Brainlab AG（Germany）
• adeor medical AG.（Germany）
• LivaNova PLC（UK）
• B. Braun SE（Germany）
• Optofine Instruments Pvt. Ltd.（India）
• Wallaby Medical（Australia）
• Terumo Medical Corporation（Japan）
• NEVRO CORP.（US）
• Integra LifeSciences（US）
• Stryker（US）
• Penumbra, Inc.（US）
• KARL STORZ SE & Co. KG（Germany）
• Nalu Medical, Inc.（US）
• Renishaw plc.（UK）
• Synapse Biomedical Inc.（US）
• EMS Handels Gesellschaft mbH（Germany）
• Inomed Medizintechnik GmbH（Germany）

結論和建議

Global Neurosurgery Market size was valued at USD 4.3 billion in 2023 and is poised to grow from USD 4.5 billion in 2024 to USD 6.45 billion by 2032, growing at a CAGR of 4.6% during the forecast period (2025-2032).

The global neurosurgery market is experiencing significant growth, fueled by several key factors. Technological innovations in neurosurgical techniques and equipment have led to more precise and minimally invasive procedures, enhancing patient outcomes and shortening recovery times. The increasing aging population coupled with a rise in neurological conditions has heightened the demand for neurosurgical interventions. Furthermore, partnerships between medical institutions and pharmaceutical companies are driving innovation in treatment options. However, the market faces high entry barriers due to the need for specialized training and expensive equipment, presenting challenges for newcomers. Overall, the neurosurgery market is set for continued expansion as it adapts to the evolving healthcare demands of a global population.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Neurosurgery market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Neurosurgery Market Segmental Analysis

Global Neurosurgery Market is segmented by Product, Age Group, Indication, Distribution Channel, End-user and region. Based on Product, the market is segmented into Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes, Neurosurgical Ablation Devices and Neurosurgery Instruments. Based on Age Group, the market is segmented into Pediatric, Adult and Geriatric. Based on Indication, the market is segmented into Brain Cancer, Spine and Skull base Tumors, Traumatic Brain Injuries, Craniofacial Trauma, Parkinson's Disease, Tourette's Syndrome and Others. Based on Distribution Channel, the market is segmented into Direct tender, Third party distributors and Others. Based on End-user, the market is segmented into Hospitals & Specialty Clinics, Ambulatory Surgical Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Neurosurgery Market

The global neurosurgery market is significantly influenced by technological advancements, which serve as a primary driver of growth. Innovations such as artificial intelligence, 5G connectivity, and the Internet of Things (IoT) are transforming the healthcare landscape by enhancing operational efficiency and unlocking new market opportunities. These cutting-edge technologies not only augment product capabilities but also elevate patient experiences, thereby propelling market expansion. As they pave the way for novel revenue streams, their integration into neurosurgery practices is set to revolutionize the industry, making it more responsive to both provider and patient needs while fostering continuous innovation and development.

Restraints in the Global Neurosurgery Market

Regulatory compliance challenges stand as a significant restraint within the Global Neurosurgery market. The ever-evolving and complex nature of regulations, particularly in sectors such as healthcare and finance, can hinder product development and limit market access. Companies frequently encounter substantial costs associated with compliance and the risk of penalties for failing to adhere to regulations. This environment necessitates that businesses effectively manage and navigate these regulatory obstacles in order to succeed in the competitive landscape of the neurosurgery market. Successfully addressing these challenges is crucial for fostering innovation and achieving sustainable growth within the industry.

Market Trends of the Global Neurosurgery Market

The global neurosurgery market is witnessing a significant trend towards minimally invasive surgical techniques, driven by a heightened demand for procedures that reduce patient risk and accelerate recovery. Advances in technology, particularly in robotic surgery and imaging guidance, are enhancing the precision and effectiveness of these methods. Patients and healthcare providers alike are increasingly favoring these minimally invasive options, as they offer lower complication rates and shorter hospital stays. This shift is expected to shape the neurosurgery landscape, leading to greater adoption of innovative techniques and technologies that improve surgical outcomes, ultimately contributing to market growth.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Study Analysis

Global Neurosurgery Market Size by Product & CAGR (2025-2032)

• Market Overview
• Neuro Interventional Devices
• Neuroendoscopes
• Neurosurgical Drills
• Radiosurgery Systems
• Dura Substitutes
• Neurosurgical Ablation Devices
• Neurosurgery Instruments

Global Neurosurgery Market Size by Age Group & CAGR (2025-2032)

• Market Overview
• Pediatric
• Adult
• Geriatric

Global Neurosurgery Market Size by Indication & CAGR (2025-2032)

• Market Overview
• Brain Cancer
• Spine and Skull base Tumors
• Traumatic Brain Injuries
• Craniofacial Trauma
• Parkinson's Disease
• Tourette's Syndrome
• Others

Global Neurosurgery Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Direct tender
• Third party distributors
• Others

Global Neurosurgery Market Size by End-user & CAGR (2025-2032)

• Market Overview
• Hospitals & Specialty Clinics
• Ambulatory Surgical Centers
• Others

Global Neurosurgery Market Size & CAGR (2025-2032)

• North America (Product, Age Group, Indication, Distribution Channel, End-user)
  • US
  • Canada
• Europe (Product, Age Group, Indication, Distribution Channel, End-user)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Age Group, Indication, Distribution Channel, End-user)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Age Group, Indication, Distribution Channel, End-user)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Age Group, Indication, Distribution Channel, End-user)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Elekta (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ALEVA NEUROTHERAPEUTICS (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Machida Endoscope Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Brainlab AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• adeor medical AG. (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun SE (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Optofine Instruments Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wallaby Medical (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Medical Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NEVRO CORP. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integra LifeSciences (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Penumbra, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• KARL STORZ SE & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nalu Medical, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Renishaw plc. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synapse Biomedical Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EMS Handels Gesellschaft mbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inomed Medizintechnik GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations